- Condition: Acute Gouty Arthritis
Interventions: Drug: ACZ885; Drug: Triamcinelone acetonide
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Recurrent or Tophacous Gout
Interventions: Other: Control; Other: Gout Disease Management Program
Sponsors: Kaiser Permanente; Kaiser Permanente
Recruiting - verified March 2012 - Conditions: Hyperuricemia; Gout
Interventions: Dietary Supplement: Blueberry Powder; Dietary Supplement: Placebo Powder
Sponsors: University of Mississippi Medical Center; University of Mississippi Medical Center
Recruiting - verified February 2012 - Conditions: Hyperuricemia; Gout
Intervention: Drug: levotofisopam
Sponsors: Pharmos; Pharmos
Recruiting - verified January 2012 - Condition: Tophaceous Gout
Interventions: Drug: Lesinurad; Drug: Lesinurad; Drug: Placebo
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified March 2012 - Condition: Gout
Interventions: Drug: Lesinurad; Drug: Lesinurad; Drug: Placebo
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified May 2012 - Condition: Gout
Interventions: Drug: lesinurad; Drug: Placebo
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified May 2012 - Condition: Gout
Interventions: Drug: Lesinurad; Drug: Lesinurad; Drug: Placebo
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified May 2012 - Conditions: Osteoarthritis; Post-traumatic Arthritis; Gout; Pseudo-gout
Intervention: Device: SIGMA HP PARTIAL KNEE
Sponsors: DePuy International; DePuy International
Recruiting - verified February 2012 - Condition: Gout
Interventions: Other: Nurse intervention; Other: Standard care
Sponsors: University of Nottingham; University of Nottingham; Arthritis Research UK
Not yet recruiting - verified November 2011 - Conditions: Prehypertension; Gout; Pulse Wave Velocity; Hypertension; 24 Hour Blood Pressure
Intervention: Drug: Febuxostat
Sponsors: University of California, San Diego; University of California, San Diego; Takeda Global Research & Development Center, Inc.
Recruiting - verified November 2011 - Condition: Chronic Gout
Intervention: Biological: pegloticase
Sponsors: Savient Pharmaceuticals; Savient Pharmaceuticals
Recruiting - verified May 2012 - Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout FlaresCondition: Gout
Interventions: Drug: Rilonacept; Drug: Placebo; Drug: Allopurinol
Sponsors: Regeneron Pharmaceuticals; Regeneron Pharmaceuticals
Recruiting - verified January 2012 - Condition: Intercritical Gout
Interventions: Drug: Colchicine; Drug: Placebo; Drug: Allopurinol
Sponsors: Regeneron Pharmaceuticals; Regeneron Pharmaceuticals
Recruiting - verified April 2012 - Condition: Acute Gouty Arthritis
Intervention: Drug: Canakinumab 150mg in prefilled syringe
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Chronic Gouty Arthritis
Intervention: Biological: canakinumab
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified November 2011 - Condition: Gout
Intervention: Drug: Allopurinol
Sponsors: Ardea Biosciences, Inc.; Ardea Biosciences, Inc.
Recruiting - verified May 2012 - Conditions: Hyperuricemia; Gout
Interventions: Dietary Supplement: green tea extracts 2 gm/day; Dietary Supplement: green tea extracts 4 gm/day; Dietary Supplement: green tea extracts 6 gm/day
Sponsors: Chiang Mai University; Chiang Mai University
Recruiting - verified October 2011 - Condition: Gouty Arthritis
Interventions: Biological: Canakinumab, ACZ885; Drug: Triamcinolone acetonide
Sponsors: Novartis; Novartis
Recruiting - verified April 2012 - Conditions: Hyperuricemia; Gout
Intervention: Drug: LC350189
Sponsors: LG Life Sciences; LG Life Sciences
Recruiting - verified April 2012 - Condition: Acute Gouty Arthritis
Interventions: Drug: Canakinumab pre-filled syringe; Drug: Canakinumab lyophilized cake; Drug: Triamcinolone Acetonide
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Conditions: Nephritis, Interstitial; Chronic Renal Failure; Gout; Renal Cysts
Intervention: Other: Blood and urine sample collections
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified May 2011 - Condition: Acute Gout
Intervention: Drug: ACZ885
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Cardiovascular Disease
Interventions: Drug: Febuxostat; Drug: Allopurinol
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified February 2012 - Condition: Joint Damage
Interventions: Drug: Febuxostat; Drug: Placebo
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified March 2012
 |
Join Clinical Trials for Gout, and other forms of Arthritis |
